1. Home
  2. IDN vs CYPH Comparison

IDN vs CYPH Comparison

Compare IDN & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$3.62

Market Cap

73.5M

Sector

Technology

ML Signal

HOLD

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$0.60

Market Cap

73.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDN
CYPH
Founded
1994
2011
Country
United States
United States
Employees
N/A
6
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.5M
73.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
IDN
CYPH
Price
$3.62
$0.60
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$7.33
N/A
AVG Volume (30 Days)
199.1K
1.6M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
N/A
EPS
0.03
N/A
Revenue
$4,433,454.00
N/A
Revenue This Year
$12.54
N/A
Revenue Next Year
$15.32
N/A
P/E Ratio
$122.67
N/A
Revenue Growth
23.21
N/A
52 Week Low
$3.59
$0.49
52 Week High
$9.08
$3.70

Technical Indicators

Market Signals
Indicator
IDN
CYPH
Relative Strength Index (RSI) 33.03 38.88
Support Level $3.59 $0.58
Resistance Level $4.49 $0.79
Average True Range (ATR) 0.15 0.05
MACD 0.01 -0.00
Stochastic Oscillator 7.94 8.51

Price Performance

Historical Comparison
IDN
CYPH

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company includes solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: